13.03.2014 Views

XXII. BIOCHEMICKÝ ZJAZD - Jesseniova lekárska fakulta

XXII. BIOCHEMICKÝ ZJAZD - Jesseniova lekárska fakulta

XXII. BIOCHEMICKÝ ZJAZD - Jesseniova lekárska fakulta

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Posters<br />

92.<br />

WILSON’s DISEaSE aND OXIDaTIve STrESS<br />

Marián Koláček 1 , Jana Muchová 1 , Eva Uhlíková 1 ,<br />

Viera Kupčová 2 and Ladislav Turecký 1<br />

1<br />

Institute of medical chemistry, biochemistry a clinical biochemistry<br />

Faculty of medicine Comenius University, Bratislava<br />

2<br />

3 th internal clinic Faculty of medicine Comenius University<br />

Wilson’s disease (hepatolenticular degeneration) is autosomal hereditary recessive<br />

disorder of copper metabolism with disorder of copper excretion into the bile and its<br />

excessive storage in some organs. Disorder is caused by mutation of the gene encoding<br />

specific copper transport protein – ATP7B for ATPase type P. Mutated ATP7B inhibits<br />

copper excretion into the bile, stimulates its direct release into the blood and its storage<br />

in organs and this leads to increased free radicals production. Decreased production<br />

of functional ceruloplasmin increases iron toxicity and thus oxidative stress becomes<br />

further increased.<br />

Our goal was to find out how are selected parameters of oxidative stress affected by<br />

Wilson’s disease. The studied group consisted of 17 patients with diagnosed Wilson’s<br />

disease (9 women and 8 men). We determined total antioxidant capacity of blood plasma<br />

(TEAC), activity of a superoxide dismutase (SOD) in erythrocytes and nitrotyrosine –<br />

marker of damage of proteins by free radicals derived from nitrogen.<br />

TEAC, as well as SOD activity in erythrocytes of patients with Wilson’s disease were higher<br />

compared to control group (2,51 mmol/l vs. 1,22 mmol/l and 11,7 U/g Hb vs. 9,2 U/g<br />

Hb). We saw no significant difference in levels of nitrotyrosine of patients and controls<br />

(54,7 nmol/l vs. 53,2 nmol/l).<br />

The increase of TEAC of blood plasma in patients with Wilson’s disease may be a compensatory<br />

response to the decline of ferooxidase activity of ceruloplasmin in serum as<br />

well as a response to increased oxidative stress in liver.<br />

216 <strong>XXII</strong>. Biochemistry Congress, Martin

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!